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A report on the Mouse Initiatives V meeting ‘Genomics of
Complex Systems in Biomedical Research’, The Jackson
Laboratory, Bar Harbor, USA, 30 July-2 August 2003.
The laboratory mouse shared center stage with many of its
distant cousins at this year’s Mouse Initiatives V meeting.
The meeting brought together close to 100 participants to
hear about and discuss the state of the art in three broad
areas: the impact of genomics on medicine, comparative
genomics, and technology. 
Comparative genomics
One of the primary themes was the importance of having
genome sequences from many diverse organisms for inter-
preting the human genome. The completion, or near comple-
tion, of genome sequences of many eukaryotic organisms has
fueled the development of powerful sequence-based strate-
gies in which many different species are compared to identify
those regions of the genome - other than protein-coding
genes - that are likely to be under selective pressure and thus
to be biologically significant. As illustrated by several of the
presentations, genome sequences from organisms other than
the usual biomedical models provide an evolutionary per-
spective on genome history and biology that resonates with
Theodosius Dobzhansky’s famous statement, “Nothing in
biology makes sense except in the light of evolution.” 
Another emphasis was on the emerging technologies that are
enabling efficient genome-wide functional analysis in the
mouse and other model organisms. The mouse is the best
animal model we have for understanding the molecular and
genetic basis of biological processes and disease in humans,
but there is still much to be done to assemble an experimen-
tal toolkit for efficient functional analysis of the mouse
genome. A common refrain was how to make the mouse more
like the fly, the worm, or yeast with respect to the genetic and
genomic strategies that can be applied to understanding the
complex connections between genotype and phenotype.
These themes are evident in the highlights from the meeting
reported in more detail here.
Elliott Margulies (National Human Genome Research Insti-
tute, Bethesda, USA) described a comparison of 1.8
megabases (Mb) of genomic sequence data surrounding the
CFTR gene (cystic fibrosis transmembrane conductance reg-
ulator) from 13 species to identify sequences that are highly
conserved across great evolutionary distances. He described
the use of a multispecies weighted conservation score to
identify conserved regions that have a higher than average
likelihood of being biologically significant. The method takes
into account the different divergence rate of each species (a
conserved region in a more divergent species will score
higher than one in more closely related species). The so-
called multispecies conserved sequences (MCSs) identified
by this method are being followed up experimentally to
determine their functional significance.
Margulies and colleagues also investigated which combina-
tion of organisms most efficiently identified the MCSs that
had been determined from a comparison of the CFTR
region from all 13 species. Taken individually, the mouse
had the third best rate of MCS identification, behind the
platypus and the hedgehog. When species were grouped
together, the quintet of dog, cow, mouse, rat and chicken
had a better detection rate than any one species by itself.
The trio of hedgehog, rat, and rabbit matched the quintet’s
sensitivity and specificity of MCS detection. Using more
than five species for MCS detection results in only modest
gains in sensitivity and specificity. But whether the results
from the CFTR region hold up for the entire genome is still
an open question. The results of the analysis described by
Margulies are currently available as a ‘Zoo’ track from the
University of California at Santa Cruz Genome Browser at
[http://genome.ucsc.edu]. 
The sea squirt Ciona intestinalis is a particularly attractive
subject for comparative genomics studies designed toexplore changes in genome content and organization during
vertebrate evolution. Ciona is an ascidian, an early chordate
that arose approximately 535 million years ago in the early
Cambrian period; its ‘tadpole’ larval stage is considered a
modern day stand-in for the ancestral chordate and reveals a
close kinship with vertebrates. Dan Rokshar (University of
California, Berkeley, USA) reported on progress in sequenc-
ing the Ciona genome. It is streamlined compared with those
of its distant vertebrate cousins: genes that tend to be
members of multigene families in vertebrates often have just
a single representative in Ciona. This makes Ciona attractive
for dissecting gene-regulation networks related to cell sig-
naling and development. The status of the sequencing effort
stands at 8.5-fold genome coverage in shotgun sequencing,
480,000 expressed sequence tags (ESTs), and 5,600 full-
length cDNAs. The estimated genome size for Ciona is 155
Mb and the net assembled length is currently 125 Mb; to
date, 15,800 genes have been annotated in the Ciona
genome. As reported by Rokshar, 63% (9,900) of the anno-
tated genes have a homolog in protostomes (Ciona and the
vertebrates are deuterostomes), and thus represent genes
that were present before the protostome-deuterostome
divergence; 17% (2,600) appear to be chordate-specific
because they have no protostome homolog but do have a ver-
tebrate counterpart; 20% (3,400) have no recognizable
homolog. These genes may be specific to the ascidian
lineage, or they may be too divergent to allow detection by
sequence similarity, or they may simply be incorrect gene-
prediction models. There is rampant genetic polymorphism
in Ciona; the average allelic polymorphism rate in an indi-
vidual organism is 1.5%, a rate 10-15-fold higher than that
reported for humans. 
New technologies 
As an example of the new technologies that are being
deployed to study gene function, George Yancopolous
(Regeneron Pharmaceuticals Inc., Tarrytown, USA) pre-
sented a functional genomics technology called VelociGene,
which can produce targeted mutations and transgenesis at a
much higher rate than can be achieved with traditional
methods. The technology relies on using large-insert clones
(bacterial artificial chromosomes, BACs) as targeting vectors
to make directed mutations in one or more genes at a time.
BAC-based vectors are created with a reporter-selection cas-
sette flanked by oligonucleotides designed to receive a spe-
cific gene. This vector is electroporated into a bacterial cell
that harbors both another BAC containing the gene of inter-
est and a plasmid that has recombination activities under
the control of a transiently inducible promoter. The result of
recombination is that the original BAC vector now harbors
the gene or genes of interest. This vector can be used to
target genes in embryonic stem (ES) cells and to replace the
native gene with the reporter via homologous recombina-
tion. The method can generate a wide range of genetic alter-
ations in the target genome, including conditional alleles,
point mutations and gene swaps (knock-ins), without the
need for isogenic targeting vectors or positive-negative selec-
tion schemes. The presence of the reporter also allows one to
identify, at high resolution, where the gene or genes of inter-
est are expressed in various cells and tissues.
The power of ES-cell technologies in mouse functional
genomics was reviewed by Andras Nagy (Mount Sinai Hos-
pital, Samuel Lunenfeld Research Institute, Toronto,
Canada), who described both loss-of-function and gain-of-
function approaches. He described a strategy of combining
ES cells with tetraploid embryos to produce mouse embryos
that are derived completely from ES cells. One of the advan-
tages of this method compared with combining diploid
embryos to produce chimeric mice is that the embryos can
be stored in liquid nitrogen and reconstituted in a matter of
weeks to produce a live mouse. Nagy reported on methods
developed in his lab that use an integrase from Streptomyces
phage phiC31 to achieve site-specific genome insertions for
transgenesis in ES cells. Germline transmission of the trans-
gene was demonstrated for two ES cell lines expressing the
integrase and it appears that integrase expression does not
affect normal mouse development. He also discussed
ongoing work to develop ES-cell-based methods for gain-of-
function screens using Cre-mediated inducible expression of
cDNAs. Finally, Nagy described the development of loss-of-
function screens for mouse chromosome 5, using mutage-
nized ES-cell libraries and markers for either positive or
negative selection to identify regions of the genome where
there has been loss of heterozygosity (the loss of the single
functional allele) due to recombination. 
Insertional mutagenesis using transposons is another way of
introducing mutations into the germline. In Drosophila,
insertional mutagenesis using endogenous transposons
called P elements has been a powerful functional genomics
tool for many years. But although transposons such as Tc
and mariner are widely distributed in animals, only inactive
forms have been identified in vertebrates. Dave Largaespada
(University of Minnesota Cancer Center, Minneapolis, USA)
reported on the development of insertional mutagenesis for
the mouse. One of the transposons being developed is Sleep-
ing Beauty, a Tc1-like transposon reconstituted from inactive
elements identified in salmonid fishes. Sleeping Beauty uses
a ‘cut and paste’ mechanism for transposition and therefore
requires no host factors for functionality; it has been shown
to be active in a wide variety of vertebrate cell types. Sleep-
ing Beauty is a two-component system: it has a transposon
and a transposase. The application of the system depends on
how the two parts of the system are combined; one can
achieve germline transgenesis, somatic cell transgenesis, or
both. Largaespada reported that transgenes within the
transposon can be expressed, and that chromosomally resi-
dent Sleeping Beauty vectors transpose in mouse soma and
germline. Most of the mouse genome appears to be accessi-
ble to transposition in this way. Sleeping Beauty insertions
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Genome Biology 2003, 4:340in the mouse genome occur within genes approximately 35%
of the time. The insertions can occur within introns or exons
and in either orientation, and in both 3 and 5 regions.
Results to date show that one can get an average of two
insertions per gamete (up to a maximum of about 10 or 12)
and that a large percentage (40-50%) of the local transposi-
tion events are closely linked to the donor site. Largaespada
outlined several possible research directions and applica-
tions of Sleeping Beauty in the mouse, including determina-
tion of the mutagenicity of Sleeping Beauty in a
phenotype-driven screen, saturation of a genomic region
using transposon mutagenesis, and transposon-assisted
chromosome engineering.
These highlights represent only some of the exciting devel-
opments reported at the conference. Participants went away
with new data and new technologies to apply to their favorite
system of study and with the sense that there are many new
experimental approaches in genetics and molecular biology
on the horizon that will further solidify the position of the
laboratory mouse as the animal model of choice for biomed-
ical research.
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